** Medtech company Becton Dickinson's BDX.N shares rise 1.80% to $252.06 premarket
** Activist investor Starboard Value has taken a stake in BDX and is pushing the company to sell its life sciences unit, the Financial Times reported, citing people familiar with the matter
** The size of Starboard's stake is unclear, the report said
** The hedge fund has met company's management team and sent a letter to the board imploring the company to sell the unit, which makes products used in clinical and research laboratories, according to the report
** BDX and Starboard did not immediately respond to a Reuters request for comment
** Stock had fallen ~7 in 2024
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.